InvestorsHub Logo
Followers 49
Posts 9770
Boards Moderated 1
Alias Born 01/31/2008

Re: ignatiusrielly35 post# 37376

Friday, 10/06/2017 12:58:09 PM

Friday, October 06, 2017 12:58:09 PM

Post# of 108191
Terry is correct that the market isn't buying it. It isn't anything unique to ADXS, pretty much all bios with revolutionary products get the same treatment. (ask AVXL)

I talked with some Wall Street Bio analysts, and was shocked that they dont' really understand this company at all. They know the name, but some thought it was one of those biologic rejuvenation companies. the problem is most analysts are finance guys, when you really need to be an MD or PhD in biochemistry to really understand if the science is going to work.

Until we get an approval, we aren't worth their time to get familiar with the listeria vaccine. Once we have an approval, the finance types can ask their usual questions about sales, market share, gross margins, etc. but they dont waste their time until an approval.

This company has been running tests for years but has NEVER scored yet...not one time in the end zone. That is what is killing the stock price. get something approved, and we will get a fresh look from the Street.

Until then, if you can get comfortable with the science, and mgt ability to get it approved, you have an opportunity to make a fortune with the warrants
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News